Evolocumab
Also known as Repatha (us)
Evolocumab injection is used to lower cholesterol (a fat-like substance in the blood) and to lower risk of a stroke or a heart attack in patients with cardiovascular disease (disease of the heart or blood vessels).
Based on 30 MLs per month. US $281.89 vs India $227.99 per ML.
The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.
- Medicine savings over 6 months
- $9,701
- Estimated travel cost
- − $2,300
- Net savings after travel
- $7,401
Even after travel, you could come out ahead by about $7,401.
Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.
Evolocumab is filled about 2.2M times a year under Medicare Part D. At the prices above, that works out to roughly:
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.